These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Characterization of microaneurysm closure after focal laser photocoagulation in diabetic macular edema. Lee SN; Chhablani J; Chan CK; Wang H; Barteselli G; El-Emam S; Gomez ML; Kozak I; Cheng L; Freeman WR Am J Ophthalmol; 2013 May; 155(5):905-12. PubMed ID: 23394906 [TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of pure yellow (577-nm) and 810-nm subthreshold micropulse laser photocoagulation combined with yellow (561-577-nm) direct photocoagulation for diabetic macular edema. Inagaki K; Ohkoshi K; Ohde S; Deshpande GA; Ebihara N; Murakami A Jpn J Ophthalmol; 2015 Jan; 59(1):21-8. PubMed ID: 25392274 [TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulation. Kim NR; Kim YJ; Chin HS; Moon YS Br J Ophthalmol; 2009 Jul; 93(7):901-5. PubMed ID: 19254904 [TBL] [Abstract][Full Text] [Related]
8. [Panretinal photocoagulation with or without focal photocoagulation--the effect on central retinal thickness]. Danielescu C; Chiseliţă D Oftalmologia; 2010; 54(2):99-103. PubMed ID: 20827919 [TBL] [Abstract][Full Text] [Related]
9. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344 [TBL] [Abstract][Full Text] [Related]
11. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter. Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176 [TBL] [Abstract][Full Text] [Related]
12. Optical coherence tomographic assessment of macular thickness and morphological patterns in diabetic macular edema: prognosis after modified grid photocoagulation. Shrestha A; Maharjan N; Shrestha A; Thapa R; Poudyal G Nepal J Ophthalmol; 2012; 4(1):128-33. PubMed ID: 22344010 [TBL] [Abstract][Full Text] [Related]
13. Retinal architecture recovery after grid photocoagulation in diabetic macular edema observed in vivo by spectral domain optical coherence tomography. Mylonas G; Bolz M; Kriechbaum K; Treu C; Deak G; Lammer J; Scholda C; Schmidt-Erfurth U Retina; 2013 Apr; 33(4):717-25. PubMed ID: 23528703 [TBL] [Abstract][Full Text] [Related]
14. Variability in photocoagulation treatment of diabetic macular oedema. van Dijk HW; Verbraak FD; Kok PH; Oberstein SY; Schlingemann RO; Russell SR; Abràmoff MD Acta Ophthalmol; 2013 Dec; 91(8):722-7. PubMed ID: 22973860 [TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography after laser photocoagulation for clinically significant macular edema. Rivellese M; George A; Sulkes D; Reichel E; Puliafito C Ophthalmic Surg Lasers; 2000; 31(3):192-7. PubMed ID: 10847494 [TBL] [Abstract][Full Text] [Related]
16. Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c). Schmid KE; Neumaier-Ammerer B; Stolba U; Binder S Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1446-52. PubMed ID: 16601980 [TBL] [Abstract][Full Text] [Related]
17. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema. Solaiman KA; Diab MM; Dabour SA Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584 [TBL] [Abstract][Full Text] [Related]
18. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710 [TBL] [Abstract][Full Text] [Related]
19. Retina rejuvenation therapy for diabetic macular edema: a pilot study. Pelosini L; Hamilton R; Mohamed M; Hamilton AM; Marshall J Retina; 2013 Mar; 33(3):548-58. PubMed ID: 23023529 [TBL] [Abstract][Full Text] [Related]
20. Barely visible 10-millisecond pascal laser photocoagulation for diabetic macular edema: observations of clinical effect and burn localization. Muqit MM; Gray JC; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE Am J Ophthalmol; 2010 Jun; 149(6):979-986.e2. PubMed ID: 20510687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]